Potential Molecular Docking of Four Acetylcholinesterase Inhibitors

Abstract

Molecular modeling attempts to study the function, structure and inhibition of the acetylcholinesterase enzyme due to the fact that the inhibition of this enzyme is importance to medical conditions such as Alzheimer’s disease, myasthenia gravis and Parkinson’s disease, and it is also important in eminent toxicological susceptibility to nerve agents. In this study we present an approach for forecasting the inhibitory activity of acetylcholinesterase (AChE) inhibitors by using docking studies. The docking studies were done on acetylcholinesterase to attain the conformation of the enzyme in water surroundings. The obtained conformation of the enzyme was used for docking with four inhibitors (physostigmine, neostigmine, pyridostigmine and rivastigmine). Docking analysis showed that hydrogen bonds and hydrophobic interactions play important tasks in the acetylcholinesterase -inhibitor complex. Subsequently, all inhibitors that bind at the catalytic site of acetylcholinesterase and their interactions with acetylcholinesterase were studied. In addition, conformation stability of acetylcholinesterase -inhibitors was studied using simulation docking technique. The complex showed that acetylcholinesterase conformation did not change significantly in the presence of the four inhibitors. This paper showed important studies on acetylcholinesterase and assists to illuminate the four inhibitors interdependencies using molecular modeling. Acetylcholine (ACh) is a neurotransmitter broadly distributed in the central and peripheral, autonomic nervous system (CNS). In the CNS, ACh performs several functions, such as memory, learning, motor control and attention. Acetylcholinesterase (AChE), one of the most essential enzymes in the family of serine hydrolases, catalyzes the hydrolysis of neurotransmitter acetylcholine, which plays an important role in memory and cognition [1-4]. It has been suggested that acetylcholinesterase (AChE) degrades the esters of choline and has a role in neurotransmission within the autonomic and somatic motor nervous systems and it is the target of action of the drugs (inhibitors) such as physostigmine, neostigmine, pyridostigmine and rivastigmine, physostigmine [1-4]. It is well known that AChE enzyme regulated the release and entrance of ACh in cholinergic fibers [5]. The function of AChE in neurological disorders like Myasthenia gravis (MG) [6], Alzheimer’s disease [7], Parkinson’s disease [8] and other ‘non-classical’ activities such as, neurite formation, network formation and cell adhesion [9] draw attention of many researches related to the medical field. The exact mechanisms of the interaction of physostigmine, neostigmine, pyridostigmine and rivastigmine with the acetylcholinesterase receptor complex still need further molecular modeling studies.

Authors and Affiliations

Nahd Mohamed Elmaki, Inass A Al Sadawi, Anton Hermann, Abdul M Gbaj

Keywords

Related Articles

Do You Know Your New Molecular Entity (NME)?

During the last decades, life science startup companies have relatively rapidly increased their presence in the pharmaceutical landscape. Pharmaceutical development has evolved because technology (analytical and process...

The Names of Drugs In “Kutadgu Bilig”

The indication includes a variety of drug names and information about how to use them for diseases. Used drug terms and names for the development of pharmacy, and types of drugs provides information on the methods of tre...

Synthesis and Anxiolytic Activity of 2- (Substituted)-5-[(N-Benzotriazolomethyl)-1,3, 4-Thiadiazolyl]-4-Thiazolidinone

1,2,3- Benzotriazole (BTA) is a heterocyclic compound with three nitrogen atoms. It is a polar and colourless compound which can be used for its great versatility. The enormous investigations on derivatives of benzotriaz...

Bioequivalent Drugs: Towards A Needed Holistic Paradigm Shift?

The author of this short communication has been working in and teaching drug development for the last 20 years. He has been involved in more than 100 drug development projects, including drug delivery, medical device, bi...

Secret Sonic Weapons’ War Lead to Carcinogenesis

State Department evacuates a number of Americans from the US consulate in Guangzhou, China after they experienced unexplained health issues. A group of US diplomats stationed in China have been brought back to the states...

Download PDF file
  • EP ID EP588181
  • DOI 10.32474/DDIPIJ.2018.02.000136
  • Views 154
  • Downloads 0

How To Cite

Nahd Mohamed Elmaki, Inass A Al Sadawi, Anton Hermann, Abdul M Gbaj (2018). Potential Molecular Docking of Four Acetylcholinesterase Inhibitors. Drug Designing & Intellectual Properties International Journal, 2(3), 191-194. https://europub.co.uk/articles/-A-588181